GAD1 and depressive symptom measurement: After excluding patients with <18 years and missing data for age, race, sex, and outcomes, the final cohort of AIS considered for the study was 5,690,773 with concurrent depression (163,226 (2.87%)), OSA (185,152 (3.25%)), and GAD (258,782 (4.55%)).